Pancreatic Cancer Research

ResearcherUniversity of WollongongActive in the last 2 years

Liguo Hao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6102-4493; OpenAlex author ID A5010490754. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 2 papers · 2026: 2 papers

Papers 8

  1. Proton Sponge-Enabled Dual-Driven Nanomotors for MRI-Guided Tumor-Penetrating Synergistic Therapy of Pancreatic Cancer. Last author DOI 10.1002/adhm.71615↗
  2. MRI-enabled ferroptosis self-amplifying nanoplatform synergizes with photothermal therapy to enhance chemotherapeutic efficacy against pancreatic cancer. Last author DOI 10.1016/j.mtbio.2026.103469↗
  3. cRGD-based MRI imaging-enhanced nanoplatform helps DOX target pancreatic cancer. Last author DOI 10.1038/s41598-025-91549-0↗
  4. Multimodal Imaging-Guided Tumor Microenvironment-Responsive Nanoplatform for Synergistic Therapy of Pancreatic Cancer. Last author DOI 10.2147/ijn.s542677↗
  5. Gelatin-coated glutathione depletion and oxygen generators in potentiated chemotherapy for pancreatic cancer. Last author DOI 10.1016/j.ijbiomac.2024.135973↗
  6. A Novel pH-Responsive Iron Oxide Core-Shell Magnetic Mesoporous Silica Nanoparticle (M-MSN) System Encapsulating Doxorubicin (DOX) and Glucose Oxidase (Gox) fo… Last author DOI 10.2147/ijn.s436253↗
  7. cRGD-Conjugated GdIO Nanoclusters for the Theranostics of Pancreatic Cancer through the Combination of T1-T2 Dual-Modal MRI and DTX Delivery. Last author DOI 10.3390/molecules28166134↗
  8. Evaluation of different b-values in DWI and 1H MRS for pancreatic cancer and pancreatitis: a rabbit model. Co-author DOI 10.1042/bsr20181933↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guangyue Shi · 4 shared papers, 2023–2025 · strength 0.89
  2. Shuai He · 2 shared papers, 2026 · strength 0.63
  3. Pan Yang · 2 shared papers, 2026 · strength 0.63
  4. Na Li · 2 shared papers, 2024–2025 · strength 0.51
  5. Na Li · 2 shared papers, 2023–2025 · strength 0.49
  6. Guiqiang Qi · 2 shared papers, 2023 · strength 0.38
  7. Shengchao Wang · 2 shared papers, 2023 · strength 0.38
  8. Silong Li · 1 shared paper, 2025 · strength 0.30
  9. Hao Zhang · 1 shared paper, 2024 · strength 0.23
  10. Hongqian Gu · 1 shared paper, 2019 · strength 0.11
  11. Xin Meng · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.